Erik Stomrud
Overview
Explore the profile of Erik Stomrud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
9053
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schinke H, Fornvik Jonsson M, Gummesson M, Nilsson R, Gaupp S, Manuilova E, et al.
Clin Chem Lab Med
. 2025 Mar;
PMID: 40068924
Objectives: The Apollo study was designed to support the clinical performance verification of the adjusted cutoffs of the Elecsys β-Amyloid(1-42) (Aβ) cerebrospinal fluid (CSF) II, β-Amyloid(1-40) (Aβ) CSF, Phospho-Tau (181P)...
2.
Karlsson L, Vogel J, Arvidsson I, Astrom K, Strandberg O, Seidlitz J, et al.
Alzheimers Dement
. 2025 Feb;
21(2):e14600.
PMID: 39985487
Introduction: Tau positron emission tomography (PET) is a reliable neuroimaging technique for assessing regional load of tau pathology in the brain, but its routine clinical use is limited by cost...
3.
Arias J, Brum W, Salvado G, Therriault J, Servaes S, Wang Y, et al.
Brain
. 2025 Jan;
PMID: 39879633
Plasma phosphorylated tau biomarkers open unprecedented opportunities for identifying carriers of Alzheimer's disease pathophysiology in early disease stages using minimally invasive techniques. Plasma p-tau biomarkers are believed to reflect tau...
4.
Cicognola C, Salvado G, Smith R, Palmqvist S, Stomrud E, Betthauser T, et al.
Brain
. 2025 Jan;
PMID: 39817469
The APOE4 allele is the strongest genetic risk factor for sporadic Alzheimer's disease (AD). While APOE4 is strongly associated with amyloid-beta (Aβ), its relationship with tau accumulation is less understood....
5.
Mastrangelo A, Mammana A, Hall S, Stomrud E, Zenesini C, Rossi M, et al.
Brain
. 2024 Dec;
PMID: 39689039
Evidence from neuropathological cohorts indicates that a CSF α-synuclein (α-syn) seed amplification assay (SAA) may provide quantitative kinetic parameters correlating with α-syn pathology burden in patients with Lewy body disease...
6.
Fernandes Gomes B, Kumar A, Ashton N, Hall S, Stomrud E, Smith R, et al.
Brain Commun
. 2024 Nov;
6(6):fcae414.
PMID: 39605973
Disease-specific fluid biomarkers are in demand for parkinsonian syndromes (PS). Corticotropin-releasing hormone (CRH) was proposed as a biomarker for Lewy body disease. As such, this project aimed to confirm CRH...
7.
Therriault J, Janelidze S, Benedet A, Ashton N, Arranz Martinez J, Gonzalez-Escalante A, et al.
Nat Aging
. 2024 Nov;
4(11):1529-1537.
PMID: 39533113
Recently approved anti-amyloid immunotherapies for Alzheimer's disease (AD) require evidence of amyloid-β pathology from positron emission tomography (PET) or cerebrospinal fluid (CSF) before initiating treatment. Blood-based biomarkers promise to reduce...
8.
Sattarov R, Havers M, Orbjorn C, Stomrud E, Janelidze S, Laurell T, et al.
Sci Rep
. 2024 Oct;
14(1):25419.
PMID: 39455624
Alzheimer's disease (AD) is a debilitating neurodegenerative disorder characterized by brain aggregation of β-amyloid (Aβ) peptides and phosphorylated tau (P-tau) proteins. Extracellular vesicles (EVs) can be isolated and studied for...
9.
Borland E, Mattson-Carlgren N, Tideman P, Stomrud E, Hansson O, Palmqvist S
Alzheimers Dement
. 2024 Oct;
20(12):8625-8638.
PMID: 39417379
Introduction: We aimed to develop an algorithm to predict the individualized risk of future dementia using brief cognitive tests suitable for primary care. Methods: We included 612 participants with subjective...
10.
Svenningsson A, Bocancea D, Stomrud E, van Loenhoud A, Barkhof F, Mattsson-Carlgren N, et al.
Alzheimers Res Ther
. 2024 Oct;
16(1):221.
PMID: 39396028
Background: In Alzheimer's disease (AD), the associations between tau pathology and brain atrophy and cognitive decline are well established, but imperfect. We investigate whether cerebrospinal fluid (CSF) biomarkers of biological...